补体介导的牛支原体杀伤在动物实验性攻毒保护中不起作用
尽管多种牛支原体蛋白疫苗可诱导显著体液免疫应答,但未能提供保护。本研究探索补体固定抗体在体外杀伤牛支原体的作用,并用能或不能诱导补体固定抗体的蛋白进行疫苗接种与攻毒实验,结果均未保护动物,提示补体固定不参与保护。
要点
- 针对部分牛支原体蛋白的抗体可在体外固定补体并杀伤牛支原体。
- 用诱导补体固定抗体或不诱导补体固定抗体的蛋白疫苗免疫后攻毒,均未产生保护。
- 结果表明补体固定对牛支原体实验性攻毒保护不起作用。
核心结论
- 补体固定抗体在体外可杀伤牛支原体,但用相应蛋白疫苗免疫不能保护动物抵抗牛支原体实验性攻毒,提示补体固定不参与保护。
研究设计与样本
- 研究包括体外杀伤实验以及用能或不能诱导补体固定抗体的牛支原体蛋白进行疫苗接种与实验性攻毒试验。
主要发现
- 针对部分牛支原体蛋白的抗体可在体外固定补体并杀伤牛支原体。
- 用诱导体液免疫应答的多种牛支原体蛋白疫苗免疫后,攻毒前后均产生显著体液免疫应答,但不足以提供保护。
- 用其同源抗体能或不能固定补体的蛋白进行疫苗接种与攻毒实验,均未产生针对牛支原体实验性攻毒的保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite numerous efforts, developing recombinant vaccines for the control of M. bovis infections has not been successful. Many factors are contributing to the lack of success including the identification of protective antigens, use of effective adjuvants, and relatively limited information on the quality of immune responses needed for protection. Experimental trials using vaccination with many M. bovis proteins resulted in significant humoral immune responses before and after the challenges, however these responses were not enough to confer protection. We explored the role of complement-fixing antibodies in the killing of M. bovis in-vitro and whether animals vaccinated with proteins that elicit antibodies capable of complement-fixing would be protected against an experimental challenge. We found that antibodies against some of these proteins fixed complement and killed M. bovis in-vitro. Vaccination and challenge experiments with proteins whose cognate antibodies either fixed complement or not resulted in lack of protection against a M. bovis experimental challenge suggesting that complement fixation does not play a role in protection.
引用
- Prysliak T, Menghwar H, Perez-Casal J, et al. Complement-mediated killing of Mycoplasma bovis does not play a role in the protection of animals against an experimental challenge. Vaccine. 2023. PMID: 36774333. doi:10.1016/j.vaccine.2023.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。